Optiva Securities
Finance · West Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Harp Ln, London, West Virginia, 25126,...Phone Number
+44 2031371902Website
www.optivasecurities.comRevenue
$5.3 MillionIndustry
About Optiva Securities
Is Optiva Securities your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Optiva Securities launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Optiva Securities is spiking on competitors!
Funding: Get notified immidiatlly once Optiva Securities has new funding data
Click to see if Optiva Securities had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Optiva Securities
Check if Optiva Securities has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Optiva Securities recently announced quarterly report
Optiva Securities, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Optiva Securities as Masked Content
Find 3 more new buyers
Compare Similar Companies to Optiva Securities
Compare insights from companies similar to Optiva Securities, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Optiva Securities
Company Profile Activity
Activity Insights
Optiva Securities is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Optiva Securities is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Optiva Securities.
Optiva Securities Tech Stack
A closer look at the technologies used by Optiva Securities
Optiva Securities News & Media
Hemogenyx Pharma Plc announces Research Collaboration with Rockefeller University
Collaboration targeting potential new treatments for Lupus using Hemogenyx's humanized mice LONDON, UK / ACCESSWIRE / May 8, 2018 / Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment of blood diseases, announces that it has entered into a collaboration agreement with The Rockefeller University ("Rockefeller"), one of the world's foremost research institutions, with 82 labsHemogenyx Pharma Plc Announces Directorate Change
- Professor Sir Marc Feldmann, Pioneer of Anti-TNF Therapy, Appointed as Executive Chairman - Anti-TNF Therapy is the World's Largest Drug Class With More Than US $36bn in Sales LONDON, UK / ACCESSWIRE / April 3, 2018 / Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment of blood diseases, announces the appointment of Sir Marc Feldmann, AC, FRS, as Executive
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Optiva Securities
Optiva Securities is a dynamic specialist stockbroker based in London, focused on providing innovative financing solutions for high growth companies and individual investors. The company aims to match the specific goals of growing companies with the wealth creation needs of its clients through its Optiva Global Marketplace. With a strong emphasis o... Read More